FDA MedWatch - Methylin CT [Methylphenidate HCl Chewable Tablets] recall due to exces

[Brian, ASN, RN]

MedWatch - The FDA Safety Information and Adverse Event Reporting Program

FDA and Alliant Pharmaceuticals notified healthcare professionals and

consumers of the voluntary recall of one lot of Methylphenidate HCl Chewable

Tablets, 5 mg strength,indicated for Attention Deficit Hyperactivity

Disorder and Narcolepsy. After testing and evaluation, Alliant found that

lot number #AMT50402A [expiration date April 2006] might contain up to three

times the active ingredient, and elected to recall the medication as it

could pose serious health risk for some patients.

Read the MedWatch 2005 safety summary, including links to the Firm Press

Release, at:

http://www.fda.gov/medwatch/SAFETY/2005/safety05.htm#Methylin